Cell Cycle (pCdk/pHH3/Actin) WB Cocktail (ab136810)
Overview
-
Product name
Cell Cycle (pCdk/pHH3/Actin) WB Cocktail -
Species reactivity
Reacts with: Mouse, Human -
Product overview
The Cell Cycle western blot cocktail (ab136810) is designed to provide a rapid assessment of cell cycle distribution based on molecular markers for the G1/S and M phases of the cell cycle. This is a mixture of three specific rabbit monoclonal primary antibodies targeting phospho-cdk2 Tyr15, phospho Histone H3 Ser10 and beta-actin. Cyclin-dependent kinase 2 (Cdk2) is maintained in an inactive state in G1/S by inhibitory phosphorylation on Tyr15. Histone H3 is phosphorylated at Ser10 when chromosomes condense during mitosis. Hence, elevated phospho-cdk2 Tyr15 indicates G1/S arrested cells and elevated phospho Histone H3 Ser10 indicates M-phase arrested cells when compared to asynchronous cycling control cells. An anti- Actin antibody is included as a loading control. These three readouts are easily resolved by western blot given their different molecular weights.
The recommended dilution for this cocktail is 1:250.
-
Tested applications
Suitable for: WBmore details
Properties
-
Storage instructions
Store at -20°C. Please refer to protocols. -
Components 200 µl 250X Cell Cycle WB Cocktail 1 x 200µl -
Research areas
Applications
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab136810 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Abreviews | Notes |
|---|---|---|
| WB |
Use at an assay dependent concentration.
1/250 dilution for primary antibody cocktail Suggested dilution buffer: 5% milk/PBS |
| Notes |
|---|
|
WB
Use at an assay dependent concentration. 1/250 dilution for primary antibody cocktail Suggested dilution buffer: 5% milk/PBS |
Images
-
Western blot – ab136810 Cell Cycle Western Blot CocktailWestern blot – ab136810 Cell Cycle Western Blot Cocktail Cdk2 pTyr15 and Histone H3 pSer10 bands are present in asynchronous cells. Cdk2 pTyr15 is elevated in G1/S arrested cells. Conversely, Histone H3 pSer10 is elevated in G2/M arrested cells. Primary antibody: All lanes Cell 250X Cell Cycle WB Cocktail diluted to 1X in 4% milk/PBS. Lane 1: HeLa lysate; Untreated, asynchronous cells Lane 2: HeLa lysate; G1/S arrested cells (thymidine treatment) Lane 3: HeLa lysate; G2/M arrested cells (sequential thymidine and nocodazole treatments) All lysates at 15 µg per lane. Lysates are ab136811 HeLa Cell Cycle Lysates Secondary antibody: All lanes anti-rabbit-HRP. Predicted band size: 42, 33, 17 kDa.
-
Western blot – ab136810 Cell Cycle Western Blot CocktailWestern blot – ab136810 Cell Cycle Western Blot Cocktail Hydroxyurea, Camptothecin and Etoposide treatments cause a G1/S-like arrest as judged by the increase in Cdk2 pTyr15 and decrease in Histone H3 pSer10 bands relative to control. In contrast, Paclitaxel causes a G2/M like arrest judged by the decreased Cdk2 pTyr15 and increased Histone H3 pSer10 bands. Primary antibody: All lanes Cell 250X Cell Cycle WB Cocktail diluted to 1X in 4% milk/PBS. Lane 1: HeLa lysate; Control treatment Lane 2: HeLa lysate; 5 mM Hydroxyurea, 24 h treatment Lane 3: HeLa lysate; 5 µM Camptothecin, 24 h treatment Lane 4: HeLa lysate; 1.5 µM Etoposide, 24 h treatment Lane 5: HeLa lysate; 2000 nM Paclitaxel, 24 h treatment All lysates at 15 µg per lane. Secondary antibody: All lanes anti-rabbit-HRP. Predicted band size: 42, 33, 17 kDa. -
Western blot – ab136810 Cell Cycle Western Blot CocktailWestern blot – ab136810 Cell Cycle Western Blot Cocktail Cdk2 pTyr15 intensity decreases and Histone H3 pSer10 intensity increases as a function of Paclitaxel concentration. Equivalent protein loading is indicated by the equal actin intensity across samples. Primary antibody: All lanes Cell 250X Cell Cycle WB Cocktail diluted to 1X in 4% milk/PBS. Lane 1: HeLa lysate; Control treatment Lane 2: HeLa lysate; 0.25 nM Paclitaxel, 24 h treatment Lane 3: HeLa lysate; 5 nM Paclitaxel, 24 h treatment Lane 4: HeLa lysate; 100 nM Paclitaxel, 24 h treatment Lane 5: HeLa lysate; 2000 nM Paclitaxel, 24 h treatment All lysates at 15 µg per lane. Secondary antibody: All lanes anti-rabbit-HRP. Predicted band size: 42, 33, 17 kDa.
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (5)
ab136810 has been referenced in 5 publications.
- Le T et al. Chimera RNA interference knockdown of ?-synuclein in human cortical astrocytes results in mitotic catastrophe. Neural Regen Res 15:1894-1902 (2020). PubMed: 32246638
- Vanoni S et al. Identification of anoctamin 1 (ANO1) as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis. J Allergy Clin Immunol 145:239-254.e2 (2020). PubMed: 31647967
- Kuo KL et al. The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study. Cells 8:N/A (2019). PubMed: 31627336
- Tong WY et al. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma. J Nanobiotechnology 16:38 (2018). PubMed: 29653579
- Planells-Palop V et al. Human germ/stem cell-specific gene TEX19 influences cancer cell proliferation and cancer prognosis. Mol Cancer 16:84 (2017). WB ; Human . PubMed: 28446200